"Atopic dermatitis is a complex disorder that's managed by a lot of different stakeholders. So within the more severe patient population in general, the two main provider categories are going to be dermatologists and allergy immunologists, which in the United States are two different fields, but of course in other parts of the world, can be one and the same. But there are certain regions of the country where you can't find a dermatologist or an allergist, and so there are family practice and other primary care providers who might actually be the ones to be the first prescriber of a systemic or biologic for tougher cases of atopic dermatitis."

For more, check out our video Q&A with Dr Silverberg, where we dive into his team's recent NEJM study on lebrikizumab for managing moderate-to-severe atopic dermatitis.